References 1) Roy SR, Sigmon JR, Olivier J, et al
Originally Developed for Diabetes: The Shift to Weight Management Originally designed for blood sugar control in type 2 diabetes, GLP-1 drugs have evolved into important therapies for obesity treatment globally
The FDA prescribing information for GLP-1 receptor agonists, including semaglutide, notes an increased risk of acute gallbladder disease (cholelithiasis, cholecystitis), which can present with jaundice and elevated liver enzymes that might be mistaken for direct liver injury
and Methionine, expediting fat breakdown and toxin elimination
Reduced Damage and Muscle Synthesis: Controls IGF-BP3 levels to promote the growth of muscle
Do labial melanotic macules go away on their own